Details for Patent: 7,550,153

Which drugs does patent 7,550,153 protect, and when does it expire?

Patent 7,550,153 protects PROTONIX and is included in one NDA.

Protection for PROTONIX has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has thirty-five patent family members in twenty-eight countries.

Summary for Patent: 7,550,153

Title:	Pantoprazole multiparticulate formulations
Abstract:	Pantoprazole sodium multiparticulates are described which avoid sticking to nasogastric and gastronomy tubes. The pantoprazole multiparticulates have a spheroid core of pantoprazole or an enantiomer thereof, or a salt thereof, a surfactant, and a disintegrant; a sub coat which is comprised of hydroxypropyl methylcellulose(hypromellose) and water, an enteric coat on the sub-coat, and a final seal coat over the enteric coat, which is composed of hydroxypropyl methylcellulose(hypromellose) and water.
Inventor(s):	Venkata Ramana Rao; Sripriya (Mahwah, NJ), Shah; Syed M. (East Hanover, NJ), Tatapudy; Hanumantharao (Suffern, NY), Saunders; Richard William (Palisades, NY), Fawzi; Mahdi (Morristown, NJ), Nagi; Arwinder (Thiells, NY), Singh; Shailesh (Bardonia, NY), Hasan; Sumon A (Monroe, NY)
Assignee:	Wyeth (Madison, NJ)
Application Number:	11/731,474
Patent Claim Types: see list of patent claims	Use; Composition; Dosage form;

Drugs Protected by US Patent 7,550,153

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Wyeth Pharms	PROTONIX	pantoprazole sodium	FOR SUSPENSION, DELAYED RELEASE;ORAL	022020-001	Nov 14, 2007	AB	RX	Yes	Yes					Y

International Family Members for US Patent 7,550,153

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	045956
Australia	2004278037
Brazil	PI0415014
Canada	2539982
China	1886119
Colombia	5690538
Costa Rica	8318